Hangzhou Alltest Biotech Co., Ltd. (688606.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.07B |
| Enterprise Value | 4.01B |
| P/E Ratio | 31.78 |
| PEG Ratio | -0.52 |
| Price/Sales Ratio | 3.86 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 1.89 |
| Enterprise/EBITDA | 12.67 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 905.34M |
| Revenue/Share | 12.35 |
| Gross Profit | 911.3M |
| EBITDA | 295.82M |
| Net Income | 220.19M |
| Diluted EPS | 2.78 |
Balance Sheet
| Total Cash | 2.08B |
| Total Cash/Share | 28.77 |
| Total Debt | 6.72M |
| Total Debt/Equity | 0 |
| Current Ratio | 10.59 |
| Book Value Per Share | 52.1 |
Price History
| 52-Week Change | -35.17 |
| 52-Week High | 72.88 |
| 52-Week Low | 39.8 |
| Moving Average 50 Days | 46.56 |
| Moving Average 200 Days | 52.3 |
Statistics
| Average Volume | 370,193 |
| Shares Outstanding | 75.65M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 4.4 |
| Payout Ratio | 1.39 |
| Last Split Factor | 37:25 |
| Last Split Date | June 09, 2023 |
AD
